Spontaneous tumour rupture and prognosis in patients with hepatocellular carcinoma

被引:114
作者
Yeh, CN [1 ]
Lee, WC [1 ]
Jeng, LB [1 ]
Chen, MF [1 ]
Yu, MC [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp, Dept Surg, Tao Yuan, Taiwan
关键词
D O I
10.1046/j.1365-2168.2002.02188.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Hepatocellular carcinoma (HCC) is a common disease in Taiwan. Ruptured HCC is an uncommon and potentially fatal complication of the condition. Information on the impact of ruptured HCC on hepatic resection is, however, limited. Methods: The clinical features of 60 patients with ruptured HCC who underwent hepatic resection from 1986 to 1998 were reviewed. Clinical features and factors influencing the outcome of 475 patients with non-ruptured HCC were used for comparison. Results: Of 535 surgically resected HCCs, 60 (11.2 per cent) were ruptured. Univariate analysis showed that sudden onset of abdominal pain, physical signs of haemodynamic unstability, reduced haemoglobin level and a raised aspartate aminotransferase level were more frequently found in patients with ruptured HCC than in those with non-ruptured tumours. Multivariate stepwise logistic regression analysis revealed sudden-onset abdominal pain to be the only independently significant factor in patients in the ruptured HCC group. The 1-, 3- and 5-year survival rates of patients with non-ruptured HCC were 72.1, 47.3 and 33.9 per cent, and those of patients with ruptured HCC were 54.2, 35.0 and 21.2 per cent respectively. Similar overall survival rates were found in patients with ruptured and non-ruptured HCC, although patients in the non-ruptured HCC group had a significantly better disease-free survival rate (P = 0.023). Conclusion: The presence of sudden-onset abdominal pain is the only independent indicator of ruptured HCC. Hepatic resection, when feasible, is the treatment of choice and can result in an overall survival rate comparable to that of patients with non-ruptured HCC.
引用
收藏
页码:1125 / 1129
页数:5
相关论文
共 16 条
[1]  
CHEN MF, 1995, HEPATO-GASTROENTEROL, V42, P166
[2]  
CHEN MF, 1988, SURG GYNECOL OBSTET, V167, P99
[3]  
CHEN MF, 1986, CANCER, V58, P332, DOI 10.1002/1097-0142(19860715)58:2<332::AID-CNCR2820580221>3.0.CO
[4]  
2-U
[5]  
CHEN MF, 1989, ARCH SURG-CHICAGO, V124, P1025
[6]  
*CHIN DEP HLTH, 1998, ANN REP CANC REG 199
[7]  
Couinaud C., 1957, FOIE ETUDES ANATOMIQ
[8]   MANAGEMENT OF BLEEDING LIVER-TUMORS IN HONG-KONG [J].
DEWAR, GA ;
GRIFFIN, SM ;
KU, KW ;
LAU, WY ;
LI, AKC .
BRITISH JOURNAL OF SURGERY, 1991, 78 (04) :463-466
[9]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
[10]  
2-E